LOIS M RAMONDETTA to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Antimetabolites, Antineoplastic.
Connection Strength
0.076
-
Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4.
Score: 0.040
-
An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. Gynecol Oncol. 2004 Jan; 92(1):314-9.
Score: 0.036